BioCentury
ARTICLE | Clinical News

Pertagen regulatory update

January 11, 2017 6:42 PM UTC

Thailand FDA approved an MAA from BioNet-Asia for Pertagen as an active booster immunization against pertussis in people ages ≥11. The company said it is the only recombinant monovalent pertussis vacc...

BCIQ Company Profiles

BioNet-Asia Co. Ltd.